PR Newswire
SUNNYVALE, Calif., Jan. 10, 2017
SUNNYVALE, Calif., Jan. 10, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at JP Morgan's 35th Annual Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis Hotel in San Francisco.
Accuray's presentation will begin at 11:30 a.m. PT and a webcast with accompanying slides will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. A replay of the webcast will also be available on the Company's website following the event.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com
Contacts | |
Investors: | Brian Moore, EVC Group, 310-770-0389 (bmoore@evcgroup.com) |
| Doug Sherk, EVC Group, 415-652-9100 (dsherk@evcgroup.com) |
| |
Media: | Beth Kaplan |
| Public Relations Director, Accuray |
| 408-789-4426 |
| bkaplan@accuray.com |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-present-at-jp-morgans-35th-annual-healthcare-conference-on-january-11-2017-300388281.html
SOURCE Accuray Incorporated
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.